Why AI Won’t Replace Human Psychotherapists
Despite AI’s growing ability to simulate empathy and even outperform humans in some areas of emotional awareness, can it truly replace human therapists and take the burden off the mental health care system?
Why We Urgently Need More Widely Available Tests for Alzheimer’s Disease
Early diagnosis through blood tests buys invaluable time – for patients and their families to plan, seek support, make informed decisions about their difficult care journey and, perhaps most importantly, be together.
GSK Wagers $80M on a Tech Platform and Parkinson’s Drug from Flagship-Founded Vesalius
Vesalius Therapeutics’ AI-based technology finds novel targets and intervention points for subgroups of patients within a common disease. A small molecule that Vesalius has been developing for a novel Parkinson’s disease target is now headed to GSK, which has licensed global rights.
Revolutionizing Breast Cancer Survivorship Care: Early Detection and Prevention of Lymphedema
Our goal should be to make lymphedema a preventable aspect of cancer survivorship or at a minimum, manageable, rather than a debilitating aftereffect that diminishes patients' quality of life.